Finance

Lists
IXHL:NASDAQ
Incannex Healthcare Inc
$3.24
-0.15%
(-0.0050) 1D
Sep 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IXHL...
Open
$3.22
High
$3.31
Low
$3.22
Mkt. cap
38.82M
Avg. vol.
89.86K
Volume
45.85K
52-wk high
$20.31
52-wk low
$2.49
EPS
-$12.90
Shares outstanding
11.96M
No. of employees
12
Open
$3.22
High
$3.31
Low
$3.22
Mkt. cap
38.82M
Avg. vol.
89.86K
Volume
45.85K
52-wk high
$20.31
52-wk low
$2.49
EPS
-$12.90
Shares outstanding
11.96M
No. of employees
12
About Incannex Healthcare Inc
CEOJoel Latham
Employees12
Founded2001
HeadquartersMelbourne, Victoria, Australia
SectorPharmaceutical industry
Analyst ratings
Based on 1 analyst giving stock ratings to IXHL in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for IXHL in the last 3 months
Highest
Current $3.24
$18.00 (+454.70%)
Average
$18.00 (+454.70%)
Lowest
$18.00 (+454.70%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Molloy
Alliance Global Partners
Buy
Initiated
$18.00
+454.7%
06/08/2026
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.13M
731.00K
1.80M
239.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.83M
5.67M
4.72M
3.73M
Operating expense
7.96M
6.40M
6.51M
3.97M
Total operating expenses
7.96M
6.40M
6.51M
3.97M
Operating income
-7.96M
-6.40M
-6.51M
-3.97M
Other non operating income
-23.17M
-
-
96.00K
EBT including unusual items
-31.60M
-6.41M
-6.52M
-3.88M
EBT excluding unusual items
-31.12M
-6.41M
-6.52M
-3.88M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-31.60M
-6.41M
-6.52M
-3.88M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.00K
5.00K
5.00K
6.00K
Interest expense
-
-
-
-
Net interest expenses
2.00K
5.00K
5.00K
6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.92M
-6.34M
-6.45M
-3.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps